Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PATTERSON, Steven E")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

Cofactor mimics as selective inhibitors of NAD-dependent inosine monophospate dehydrogenase (IMPDH): the major therapeutic target : Nicotinamide adenine dinucleotide (NAD); chemistry and its role in biology and medicinePANKIEWICZ, Krzysztof W; PATTERSON, Steven E; BLACK, Paul L et al.Current medicinal chemistry. 2004, Vol 11, Num 7, pp 887-900, issn 0929-8673, 14 p.Article

Cyanide Toxicity in Juvenile Pigs and Its Reversal by a New Prodrug, Sulfanegen SodiumBELANI, Kumar G; SINGH, Harpreet; BEEBE, David S et al.Anesthesia and analgesia. 2012, Vol 114, Num 5, pp 956-961, issn 0003-2999, 6 p.Article

Discovery of drugs that possess activity against feline leukemia virusGREGGS, Willie M; CLOUSER, Christine L; PATTERSON, Steven E et al.Journal of general virology. 2012, Vol 93, pp 900-905, issn 0022-1317, 6 p., 4Article

Probing binding requirements of NAD kinase with modified substrate (NAD) analoguesBONNAC, Laurent; LIQIANG CHEN; MAGNI, Giulio et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 6, pp 1512-1515, issn 0960-894X, 4 p.Article

A novel paradigm for assessing efficacies of potential antidotes against neurotoxins in miceCRANKSHAW, Daune L; GOON, David J. W; BRIGGS, Jacquie E et al.Toxicology letters. 2007, Vol 175, Num 1-3, pp 111-117, issn 0378-4274, 7 p.Article

Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analoguesLIQIANG CHEN; GUANGYAO GAO; FELCZAK, Krzysztof et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 23, pp 5743-5751, issn 0022-2623, 9 p.Article

Synthesis of N3, 5'-Cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activityPEIYUAN WANG; HOLLECKER, Laurent; SCHINAZI, Raymond F et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 24, pp 6100-6103, issn 0022-2623, 4 p.Article

Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell linesYALOWITZ, Joel A; PANKIEWICZ, Krzysztof; PATTERSON, Steven E et al.Cancer letters. 2002, Vol 181, Num 1, pp 31-38, issn 0304-3835Article

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabineCLOUSER, Christine L; CHAUHAN, Jay; BESS, Matthew A et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 21, pp 6642-6646, issn 0960-894X, 5 p.Article

Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicityBRENNER, Matthew; KIM, Jae G; PATTERSON, Steven E et al.Toxicology and applied pharmacology. 2010, Vol 248, Num 3, pp 269-276, issn 0041-008X, 8 p.Article

Rational design and synthesis of novel nucleotide anti-Giardia agentsSUK, Dae-Hwan; BONNAC, Laurent; DYKSTRA, Christine C et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 7, pp 2064-2067, issn 0960-894X, 4 p.Article

Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replicationCLARK, Jeremy L; HOLLECKER, Laurent; FURMAN, Phillip A et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 17, pp 5504-5508, issn 0022-2623, 5 p.Article

  • Page / 1